Inhibition of STAT3 by Anticancer Drug Bendamustine

• Kazunori Iwamoto,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Yutaka Uehara,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Yukie Inoue,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Kyoko Taguchi,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Daisuke Muraoka,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Naohisa Ogo,

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Kenji Matsuno,

  Current address: Department of Chemistry and Life Science, Kogakuin University, Hachi-oji, Tokyo, Japan

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯
• Akira Asai

  * E-mail: aasai@u-shizuoka-ken.ac.jp

  Affiliation Center for Drug Discovery, Graduate School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan

  ⨯